Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Pacific Eye Associates | Researchclopedia

Back to institutions

Pacific Eye Associates

San Franciscohealthcare

152

Works

4,273

Citations

29

h-index

Top Research Topics

Retinal Diseases and Treatments Glaucoma and retinal disorders Retinal and Optic Conditions

Top Researchers

Wayne L. Hubbell Doheny Eye Institute

334 works29,265 citationsh-index: 94

Recent Research

BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

Retinal Imaging and Analysis

Intraocular Surgery and Lenses

Corneal surgery and disorders

Ocular Diseases and Behçet’s Syndrome

Colorectal Cancer Treatments and Studies

Ophthalmology and Visual Impairment Studies

Lung Cancer Treatments and Mutations

Multiple Myeloma Research and Treatments

Retinal and Macular Surgery

Michael R. Hee Massachusetts Institute of Technology

79 works25,862 citationsh-index: 30

Ari David Baron

106 works24,444 citationsh-index: 35

William Stewart Johns Hopkins University

412 works23,886 citationsh-index: 72

Arlène Fink University of California, Los Angeles

278 works15,798 citationsh-index: 55

Fernando López‐Ríos Universidad Autónoma de Nuevo León

360 works11,670 citationsh-index: 56

A phase 1b/2 study on the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

Bxq-350 in combination with FOLFOX7 and bevacizumab: Evaluation of effect on oxaliplatin-induced CIPN—A phase 1b/2 trial to assess the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in newly diagnosed metastatic colorectal carcinoma.

Tariq Arshad,Michael Gazda,et al.

20260 citations

Ocular manifestations of vaccine-preventable diseases: A comprehensive review

Kayne McCarthy,Rona Z. Silkiss

20250 citations

Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled Trial

Eydie Miller-Ellis,James H. Peace,et al.

20250 citations

134eP Observed survival following treatment with leronlimab in patients with metastatic colorectal cancer

Andre T. Baron,Candan Arman,et al.

20250 citations